IntERact Behavior Intervention for Firearm Carrying
Trial Summary
What is the purpose of this trial?
The present study is evaluating the efficacy of a behavioral intervention to reduce risky firearm carriage among a high risk sample of youth reporting recent firearm carriage and ownership of a smartphone.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment IntERact Behavior Intervention for Firearm Carrying?
How is the IntERact treatment different from other treatments for firearm carrying?
The IntERact treatment is unique because it focuses on behavioral intervention to address firearm carrying, which is not typically targeted by standard medical treatments. It likely involves community education and engagement strategies, similar to programs like Ceasefire Oregon, which use education and outreach to reduce gun violence.46789
Research Team
Patrick Carter, M.D.
Principal Investigator
University of Michigan
Eligibility Criteria
This trial is for Flint or Saginaw youth aged 16-24 who have carried a firearm in the past 3 months and own a smartphone. Participants must be able to consent (or provide assent with parental consent if under 18) and not be incarcerated, mentally incapacitated, or seeking emergency care for suicide, sexual assault, or child abuse.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive three remotely delivered behavioral therapy sessions integrating motivational interviewing, cognitive behavioral therapy, and care management, supported by a smartphone app.
Follow-up
Participants are monitored for changes in risky firearm behaviors, aggression, and victimization at 3 and 6 months post-baseline.
Treatment Details
Interventions
- IntERact
IntERact is already approved in United States for the following indications:
- Reducing risky firearm behaviors among youth
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator